407
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Ankle plantarflexor spasticity is not differentially disabling for those who are weak following traumatic brain injury

, , &
Pages 193-198 | Received 13 Apr 2016, Accepted 26 Jul 2016, Published online: 23 Nov 2016

References

  • Sommerfeld DK, Eek EU, Svensson A, Holmqvist LW, von Arbin MH. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004;35:134–139.
  • Sosnoff JJ, Gappmaier E, Frame A, Motl RW. Influence of spasticity on mobility and balance in persons with multiple sclerosis. Journal of Neurologic Physical Therapy 2011;35:129–132.
  • Urban PP, Wolf T, Uebele M, Marx JJ, Vogt T, Stoeter P, et al. Occurrence and clinical predictors of spasticity after ischemic stroke. Stroke 2010;41:2016–2020.
  • Wissel J, Schelosky LD, Scott J, Christe W, Jurgen FH, Mueller J. Early development of spasticity following stroke: a prospective, observational trial. Journal of Neurology 2010;257:1067–1072.
  • Olver J, Esquenazi A, Fung VSC, Singer BJ, Ward AB, Institute CP. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement. European Journal of Neurology 2010;17(Suppl 2):57–73.
  • Sheean G, Lannin NA, Turner-Stokes L, Rawicki B, Snow BJ, Cerebral Palsy I. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. European Journal of Neurology 2010;17(Suppl 2):74–93.
  • Thurman D, Alverson C, Browne D, Dunn K, Guevro J, Johnson R, et al. Traumatic brain injury in the United States: a report to Congress [Internet]. 1999. US Department of Health and Human Services Centers for Disease Control and Prevention National Center for Injury Prevention and Control. Available from http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF.
  • Dumas HM, Haley SM, Ludlow LH, Carey TM. Recovery of ambulation during inpatient rehabilitation: physical therapist prognosis for children and adolescents with traumatic brain injury. Physical Therapy 2004;84:232–242.
  • Fock J, Galea MP, Stillman BC, Rawicki B, Clark M. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Injury 2004;18:57–63.
  • Keenan MA. Surgical decision making for residual limb deformities following traumatic brain injury. Orthopedic Reviews 1988;17:1185–1192.
  • Dietz V, Sinkjaer T. Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurology 2007;6:725–733.
  • Umberger BR, Martin PE. Mechanical power and efficiency of level walking with different stride rates. The Journal of Experimental Biology 2007;210:3255–3265.
  • Robertson JVG, Pradon D, Bensmail D, Fermanian C, Bussel B, Roche N. Relevance of botulinum toxin injection and nerve block of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults. Gait & Posture 2009;29:108–112.
  • Esquenazi A. Evaluation and management of spastic gait in patients with traumatic brain injury. Journal of Head Trauma Rehabilitation 2004;19:109–118.
  • Perry J. The use of gait analysis for surgical recommendations in traumatic brain injury. The Journal of Head Trauma Rehabilitation 1999;14:116–135.
  • Williams G, Banky M, Olver J. Distribution of lower limb spasticity does not influence mobility outcome following traumatic brain injury: an observational study. The Journal of Head Trauma Rehabilitation 2015;30:E49–E57.
  • Williams G, Banky M, Olver J. Ankle plantarflexor spasticity does not restrict the recovery of ankle plantarflexor strength or ankle power generation for push-off during walking following traumatic brain injury. The Journal of Head Trauma Rehabilitation 2016;31:E52–E58.
  • Williams G, Banky M, Olver J. Severity and distribution of spasticity does not limit mobility or influence compensatory strategies following traumatic brain injury. Brain Injury 2015;29:1232–1238.
  • Williams GP, Schache AG, Morris ME. Mobility after traumatic brain injury: relationships with ankle joint power generation and motor skill level. The Journal of Head Trauma Rehabilitation 2013;28:371–378.
  • Requiao LF, Nadeau S, Milot MH, Gravel D, Bourbonnais D, Gagnon D. Quantification of level of effort at the plantarflexors and hip extensors and flexor muscles in healthy subjects walking at different cadences. Journal of Electromyography & Kinesiology 2005;15:393–405.
  • Neptune RR, Sasaki K, Kautz SA. The effect of walking speed on muscle function and mechanical energetics. Gait & Posture 2008;28:135–143.
  • Sawicki GS, Lewis CL, Ferris DP. It pays to have a spring in your step. Exercise and sport sciences reviews 2009;37:130–138.
  • Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet 1975;1:480–484.
  • Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European Journal of Neurology 1999;6:23–35.
  • Gracies J, Marosszeky JE, Renton R, Sandanam J, Gandevia SC, Burke D. Short-term effects of dynamic Lycra splints on upper limb in hemiplegic patients. Archives of Physical Medicine & Rehabilitation 2000;81:1547–1555.
  • Williams G, Robertson V, Greenwood K. Measuring high-level mobility after traumatic brain injury. American Journal of Physical Medicine & Rehabilitation 2004;83:910–920.
  • Williams G, Robertson V, Greenwood K, Goldie P, Morris ME. The high-level mobility assessment tool (HiMAT) for traumatic brain injury. Part 1: item generation. Brain Injury 2005;19:925–932.
  • Williams GP, Robertson V, Greenwood KM, Goldie PA, Morris ME. The high-level mobility assessment tool (HiMAT) for traumatic brain injury. Part 2: content validity and discriminability. Brain Injury 2005;19:833–843.
  • Williams GP, Greenwood KM, Robertson VJ, Goldie PA, Morris ME. High-Level Mobility Assessment Tool (HiMAT): interrater reliability, retest reliability, and internal consistency. Physical Therapy 2006;86:395–400.
  • Williams G, Robertson V, Greenwood K, Goldie P, Morris ME. The concurrent validity and responsiveness of the High-Level Mobility Assessment Tool for measuring the mobility limitations of people with traumatic brain injury. Archives of Physical Medicine & Rehabilitation 2006;87:437–442.
  • Stark T, Walker B, Phillips JK, Fejer R, Beck R. Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review. Physical Medicine & Rehabiliation 2011;3:472–479.
  • Morris SL, Dodd KJ, Morris ME. Reliability of dynamometry to quantify isometric strength following traumatic brain injury. Brain Injury 2008;22:1030–1037.
  • Williams G, Morris ME, Schache A, McCrory PR. Incidence of gait abnormalities after traumatic brain injury. Archives of Physical Medicine and Rehabilitation 2009;90:587–593.
  • Hollander M, Wolfe DA, Chicken E. Nonparametric statistical methods. 3rd ed. Hoboken (NJ): Wiley; 2014.
  • Andersen R. Modern methods for robust regression. Thousand Oaks (CA): Sage; 2008.
  • Cohen J, Cohen P, West SG, Aiken LS, Applied multiple regression /correlation analysis for the behavioral sciences. 3rd ed. Mahwah (NJ): Erlbaum; 2003.
  • Shores EA, Marosszeky JE, Sandanam J, Batchelor J. Preliminary validation of a clinical scale for measuring the duration of post-traumatic amnesia. Medical Journal of Australia 1986;144:569–572.
  • Richardson D, Sheean G, Werring D, Desai M, Edwards S, Greenwood R, et al. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. Journal of Neurology, Neurosurgery & Psychiatry 2000;69:499–506.
  • Bayram S, Sivrioglu K, Karli N, Ozcan O. Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study. American Journal of Physical Medicine and Rehabilitation 2006;85:75–81.
  • Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurological Sciences 2005;26:26–31.
  • Moore EJ, Banky M, Olver J, Bryant AL, Williams G. The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: a systematic review. Brain Injury 2015;29:676–687.
  • Williams G, Kahn M, Randall A. Strength training for walking in neurologic rehabilitation is not task specific: a focused review. American Journal of Physical Medicine & Rehabilitation 2014;93:511–522.
  • van der Krogt MM, Doorenbosch CAM, Becher JG, Harlaar J. Walking speed modifies spasticity effects in gastrocnemius and soleus in cerebral palsy gait. Clinical Biomechanics (Bristol, Avon) 2009;24:422–428.
  • Williams G, Schache AG. The distribution of positive work and power generation amongst the lower-limb joints during walking normalises following recovery from traumatic brain injury. Gait & Posture 2016;43:265–269.
  • van der Krogt MM, Delp SL, Schwartz MH. How robust is human gait to muscle weakness? Gait & Posture 2012;36:113–119.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.